{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T22:52:00Z","timestamp":1790981520176,"version":"4.1.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2000,8,1]],"date-time":"2000-08-01T00:00:00Z","timestamp":965088000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res"],"published-print":{"date-parts":[[2000,8]]},"DOI":"10.1186\/bcr67","type":"journal-article","created":{"date-parts":[[2002,9,26]],"date-time":"2002-09-26T08:07:27Z","timestamp":1033027647000},"source":"Crossref","is-referenced-by-count":18,"title":["Future possibilities in the prevention of breast cancer: Luteinizing hormone-releasing hormone agonists"],"prefix":"10.1186","volume":"2","author":[{"given":"Darcy V","family":"Spicer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malcolm C","family":"Pike","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2000,8,1]]},"reference":[{"key":"67_CR1","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1038\/bjc.1989.237","volume":"60","author":"MC Pike","year":"1989","unstructured":"Pike MC, Ross RK, Lobo RA, Key TJA, Potts M, Henderson BE: LHRH agonists and the prevention of breast and ovarian cancer. Br J Cancer. 1989, 60: 142-148., Detailed explanation of the rationale for considering the use of LHRH agonists for breast cancer prevention.","journal-title":"Br J Cancer"},{"key":"67_CR2","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1002\/1097-0142(195609\/10)9:5<927::AID-CNCR2820090510>3.0.CO;2-3","volume":"9","author":"A Lilienfeld","year":"1956","unstructured":"Lilienfeld A: The relationship of cancer of the female breast to artificial menopause and marital status. Cancer. 1956, 9: 927-934.","journal-title":"Cancer"},{"key":"67_CR3","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1002\/1097-0142(196201\/02)15:1<28::AID-CNCR2820150105>3.0.CO;2-3","volume":"15","author":"T Hirayama","year":"1962","unstructured":"Hirayama T, Wynder EL: A study of the epidemiology of cancer of the breast II. The influence of hysterectomy. Cancer. 1962, 15: 28-38.","journal-title":"Cancer"},{"key":"67_CR4","first-page":"315","volume":"41","author":"M Feinleib","year":"1968","unstructured":"Feinleib M: Breast cancer and artificial menopause: a cohort study. J Natl Cancer Inst. 1968, 41: 315-329.","journal-title":"J Natl Cancer Inst"},{"key":"67_CR5","first-page":"605","volume":"48","author":"D Trichopoulos","year":"1972","unstructured":"Trichopoulos D, MacMahon B, Cole P: Menopause and breast cancer risk. J Natl Cancer Inst. 1972, 48: 605-613.","journal-title":"J Natl Cancer Inst"},{"key":"67_CR6","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1093\/oxfordjournals.epirev.a036215","volume":"1","author":"J Kelsey","year":"1979","unstructured":"Kelsey J: A review of the epidemiology of human breast cancer. Epidemiol Rev. 1979, 1: 74-109.","journal-title":"Epidemiol Rev"},{"key":"67_CR7","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1093\/jnci\/91.17.1475","volume":"91","author":"R Rebbeck","year":"1999","unstructured":"Rebbeck R, Levin A, Eisen A, et al: Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers. J Natl Cancer Inst. 1999, 91: 1475-1479. 10.1093\/jnci\/91.17.1475.","journal-title":"J Natl Cancer Inst"},{"key":"67_CR8","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1126\/science.2136249","volume":"249","author":"BN Ames","year":"1990","unstructured":"Ames BN, Gold LS: Too many rodent carcinogens: mitogenesis increases mutagenesis. Science. 1990, 249: 970-971.","journal-title":"Science"},{"key":"67_CR9","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/oxfordjournals.epirev.a036102","volume":"15","author":"MC Pike","year":"1993","unstructured":"Pike MC, Spicer DV, Dahmoush L, Press MF: Estrogens, progestogens, normal breast cell proliferation and breast cancer risk. Epidemiol Rev. 1993, 15: 17-35., Review of the effects of ovarian hormones on normal breast epithelial cell proliferation","journal-title":"Epidemiol Rev"},{"key":"67_CR10","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1200\/JCO.1989.7.8.1113","volume":"7","author":"M Kaufman","year":"1989","unstructured":"Kaufman M, Jonat W, Kleeberg U, et al: Goserelin, a depot gonadotrophin-releasing hormone agonist in the treatment of premenopausal patients with metastatic breast cancer. J Clin Oncol . 1989, 7: 1113-1119.","journal-title":"J Clin Oncol"},{"key":"67_CR11","first-page":"30","volume":"57","author":"M Baum","year":"1999","unstructured":"Baum M: Adjuvant treatment of premenopausal breast cancer with zoladex and tamoxifen [abstract]. Breast Cancer Res Treat. 1999, 57: 30-","journal-title":"Breast Cancer Res Treat"},{"key":"67_CR12","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/S0021-9681(87)80009-7","volume":"40","author":"MC Pike","year":"1987","unstructured":"Pike MC: Age-related factors in cancer of the breast, ovary and endometrium. J Chron Dis. 1987, 40: 59-69.","journal-title":"J Chron Dis"},{"key":"67_CR13","volume-title":"J Natl Cancer Inst","author":"D Spicer","year":"1991","unstructured":"Spicer D, Shoupe D, Pike M: Gonadotropin-releasing hormone agonist plus add-back sex steroids to reduce risk of breast cancer [letter; comment]. J Natl Cancer Inst. 1991, 83:"},{"key":"67_CR14","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1093\/jnci\/92.4.328","volume":"92","author":"RK Ross","year":"2000","unstructured":"Ross RK, Paganini-Hill A, Wan PC, Pike MC: Estrogen versus estrogen-progestin hormone replacement therapy: effect on breast cancer risk. J Natl Cancer Inst. 2000, 92: 328-332. 10.1093\/jnci\/92.4.328.","journal-title":"J Natl Cancer Inst"},{"key":"67_CR15","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/0010-7824(91)90019-C","volume":"44","author":"DV Spicer","year":"1991","unstructured":"Spicer DV, Shoupe D, Pike M: GnRH agonists as contraceptive agents: predicted significantly reduced risk of breast cancer. Contraception. 1991, 44: 289-310. 10.1016\/0010-7824(91)90019-C.","journal-title":"Contraception"},{"key":"67_CR16","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/0010-7824(93)90095-O","volume":"47","author":"DV Spicer","year":"1993","unstructured":"Spicer DV, Pike MC, Pike A, Rude R, Shoupe D, Richardson J: Pilot trial of a gonadotropin hormone agonist with replacement hormones as a prototype contraceptive to prevent breast cancer. Contraception. 1993, 47: 427-444. 10.1016\/0010-7824(93)90095-O.","journal-title":"Contraception"},{"key":"67_CR17","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1093\/jnci\/86.6.431","volume":"86","author":"D Spicer","year":"1994","unstructured":"Spicer D, Ursin G, Parisky Y, et al: Changes in mammographic densities induced by a hormonal contraceptive designed to reduce breast cancer risk. J Natl Cancer Inst. 1994, 86: 431-436.","journal-title":"J Natl Cancer Inst"},{"key":"67_CR18","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1093\/oxfordjournals.epirev.a036300","volume":"9","author":"AF Saftlas","year":"1987","unstructured":"Saftlas AF, Szklo M: Mammographic parenchymal patterns and breast cancer risk. Epidemiol Rev. 1987, 9: 146-174.","journal-title":"Epidemiol Rev"},{"key":"67_CR19","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1093\/jnci\/80.19.1534","volume":"80","author":"J Brisson","year":"1988","unstructured":"Brisson J, Morrison AS, Khalid N: Mammographic parenchymal features and breast cancer in the brest cancer detection demonstration project. J Natl Cancer Inst. 1988, 80: 1532-1540.","journal-title":"J Natl Cancer Inst"},{"key":"67_CR20","first-page":"67","volume":"16","author":"E Warner","year":"1992","unstructured":"Warner E, Lockwood G, Tritchler D, Boyd NF: The risk of breast cancer associated with mammographic parenchymal patterns: a meta-analysis of the published literature to examine the effect of method of classification. Cancer Detect Prev. 1992, 16: 67-72.","journal-title":"Cancer Detect Prev"},{"key":"67_CR21","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1093\/oxfordjournals.epirev.a036105","volume":"15","author":"AM Oza","year":"1993","unstructured":"Oza AM, Boyd NF: Mammographic parenchymal patterns: a marker of breast cancer risk. Epidemiol Rev. 1993, 15: 196-208.","journal-title":"Epidemiol Rev"}],"container-title":["Breast Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/bcr67.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/bcr67\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/bcr67.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,12,31]],"date-time":"2017-12-31T19:22:08Z","timestamp":1514748128000},"score":1,"resource":{"primary":{"URL":"http:\/\/breast-cancer-research.biomedcentral.com\/articles\/10.1186\/bcr67"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,8]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2000,8]]}},"alternative-id":["67"],"URL":"https:\/\/doi.org\/10.1186\/bcr67","relation":{},"ISSN":["1465-542X"],"issn-type":[{"value":"1465-542X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,8]]},"article-number":"264"}}